NCT03145376

Brief Summary

Since October of 2014, the Policlinico Umberto I Hospital has an "Heart Team", a group of selected specialists with the task of assessing and identifying eligible patients for valvular aortic transcatheter implantation (TAVI) or a placement of a MitraClip . The specialists taking part to Heart Team are: a cardiologist, a heart surgeon, a vascular surgeon, an anesthesiologist and a geriatrician. The Geriatrician is called to make a careful multidimensional assessment of the elderly patients who have been suggested for the interventions mentioned above. His role is to assess the degree of co-morbidity and polypathology, autonomy in the common activities of daily living, nutritional status, cognitive status and quality of life. Following this evaluation, together with the other components of Heart Team, it is expressed a collective judgment on the patient's eligibility to these interventions. So, the aim of the present study is to identify changes in the degree of cognitive decline, of autonomy in carrying out activities of daily living, quality of life, nutritional status, pre- and postoperatively (6 months after the procedure) polypathology degree in elderly patients to be undergone or undergoing TAVI or positioning MitraClip because suffering from aortic valvular stenosis or severe mitral insufficiency. The patients undergo to a battery of tests, to a 5 minutes electrocardiographic record to evaluate the Heart Rate Variability (HRV) and to a complete echocardiographic evaluation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2017

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 27, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 9, 2017

Completed
23 days until next milestone

Study Start

First participant enrolled

June 1, 2017

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2020

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2020

Completed
Last Updated

October 30, 2017

Status Verified

October 1, 2017

Enrollment Period

3 years

First QC Date

March 27, 2017

Last Update Submit

October 26, 2017

Conditions

Keywords

TAVIMitraClipgeriatric assessmentheart rate variabilityelderly

Outcome Measures

Primary Outcomes (1)

  • Changes in cognitive impairment evaluation using minimental state examination (MMSE)

    evaluation of the pre and post-operative cognitive impairment using the same test (mini mental state examination, MMSE: tot 28-30 points no cognitive impairment, 24-27 borderline, 19-23 mild cognitive impairment, 14-18 moderate cognitive impairment, \<14 severe cognitive impairment)

    Baseline evaluation and a new one after 6 months to evaluate possible changes

Secondary Outcomes (6)

  • Quality of Life

    Baseline evaluation and a new one after 6 months

  • polypathology status evaluation with CIRS scale

    Baseline evaluation and a new one after 6 months

  • ADL: Activities of Daily Living

    Baseline evaluation and a new one after 6 months

  • IADL:InstrumentalActivities of Daily Living

    Baseline evaluation and a new one after 6 months

  • MNA:Mini Nutritional Assessment

    Baseline evaluation and a new one after 6 months

  • +1 more secondary outcomes

Study Arms (1)

patients before and after TAVI/MitraClip

geriatric assessment of patients before and after TAVI/Mitraclip

Diagnostic Test: geriatric assessment

Interventions

geriatric assessmentDIAGNOSTIC_TEST

1. Clinical evaluation and geriatric assessment with: 1. CIRS: CIRS (Cumulative Illness Rating Scale) 2. ADL (Activities of Daily Living); 3. IADL (InstrumentalActivities of Daily Living); 4. Mini Nutritional Assessment; 5. Evaluation of quality of life (Short Form 36, SF-36). 2. Making a traditional 12-lead ECG. 3. A single lead electrocardiographic registration (DI, D II and D III) of 5 minutes baseline and 5 minutes with controlled breathing (15 breaths / min), using the Spectralink 2011 program, which allows us to identify and calculate the variables object of study; 4. transthoracic echocardiogram.

Also known as: ECG, Heart Rate Variability, Echocardiogram
patients before and after TAVI/MitraClip

Eligibility Criteria

Age65 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

elderly patients with severe aortic stenosis eligible for TAVI or affected by mitral valve severe insufficiency treatable by MitraClip positioning.

You may qualify if:

  • Age higher than or equal to 65 aa;
  • the capacity to perform geriatric assessment tests;
  • sinus rhythm at the time of evaluation (for the evaluation of HRV only);
  • to sign appropriate informed consent.

You may not qualify if:

  • altered cognitive abilities such as to impair the evaluation;
  • hemodynamically unstable patient;
  • Inability or unwillingness to sign informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Gianfranco Piccirillo

Rome, 00186, Italy

NOT YET RECRUITING

Policlinico Umberto I

Rome, 00186, Italy

RECRUITING

Related Publications (1)

  • Piccirillo G, Moscucci F, Mastropietri F, Di Iorio C, Mariani MV, Fabietti M, Stricchiola GM, Parrotta I, Sardella G, Mancone M, Magri D. Possible predictive role of electrical risk score on transcatheter aortic valve replacement outcomes in older patients: preliminary data. Clin Interv Aging. 2018 Sep 11;13:1657-1667. doi: 10.2147/CIA.S170226. eCollection 2018.

MeSH Terms

Conditions

Mitral Valve Insufficiency

Interventions

ElectrocardiographyEchocardiography

Condition Hierarchy (Ancestors)

Heart Valve DiseasesHeart DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Heart Function TestsDiagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosisElectrodiagnosisCardiac Imaging TechniquesDiagnostic ImagingUltrasonography

Study Officials

  • Gianfranco Piccirillo, MD, PhD

    Sapienza

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gianfranco Piccirillo, MD, PhD

CONTACT

Federica Moscucci, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate professor

Study Record Dates

First Submitted

March 27, 2017

First Posted

May 9, 2017

Study Start

June 1, 2017

Primary Completion

May 30, 2020

Study Completion

October 30, 2020

Last Updated

October 30, 2017

Record last verified: 2017-10

Data Sharing

IPD Sharing
Will not share

Locations